WHO Leaders Discuss PEN-Plus at the World Health Assembly

WHO Leaders Discuss PEN-Plus at the World Health Assembly

Leaders from the World Health Organization Regional Office for Africa (WHO AFRO), WHO Headquarters, and other stakeholders invested in the implementation of PEN-Plus met in Geneva on 24 May to discuss PEN-Plus as a key strategy for decentralizing care for severe NCDs and providing the world’s most vulnerable with accessible and affordable health care for chronic conditions including type 1 diabetes (T1D), sickle cell disease (SCD), and rheumatic and congenital heart disease (RHD/CHD).

Read More

Network Co-Chairs Dr. Ana Mocumbi and Dr. Gene Bukhman travel to Sofala Province ahead of PEN-Plus implementation in Mozambique

Network Co-Chairs Dr. Ana Mocumbi and Dr. Gene Bukhman travel to Sofala Province ahead of PEN-Plus implementation in Mozambique

NCDI Poverty Network Co-Chair Dr. Ana Mocumbi and the Mozambique Co-Secretariat and Southern Africa Regional Hub team recently hosted NCDI Poverty Network Co-Chair Dr. Gene Bukhman and Director of Programs Dr. Emily Wroe for a three-day visit to the provinces of Maputo and Sofala as Mozambique prepares to implement PEN-Plus.

Read More

Network Co-Secretariat and Southern Africa Regional Hub launched at Universidade Eduardo Mondlane

Network Co-Secretariat and Southern Africa Regional Hub launched at Universidade Eduardo Mondlane

More than 40 leading NCDI policy makers, researchers, care providers, and advocates, including the Minister of Health, His Excellency Dr. Armindo Tiago, and Dr. Orlando António Quilambo, Rector of Universidade Eduardo Mondlane (UEM), convened in Maputo on 27 October for the launch of the Mozambique Co-Secretariat and Southern Africa Regional Hub of the NCDI Poverty Network, which will be based at UEM.

Read More

PEN-Plus Partnership holds first internal All-Partner meeting

The PEN-Plus Partnership convened its first All-Partner Internal Meeting on 23 June 2021. The meeting brought together representatives of 23 global and regional organizations that focus on type 1 diabetes, sickle cell disease, and rheumatic and congenital heart disease to review the goals, governance, and terms of reference (ToRs) of the Partnership, to learn about the structure and preliminary workplans of five Partnership working groups, and to discuss which of the working groups their organizations would be interested in joining.

Read More